Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responses
Abstract Clinical research generally focuses on results involving a statistical mean with little attention in trial design to patients who respond considerably better or worse than average. Exploring the reasons underlying an “atypical response” will increase understanding of the mechanisms involved...
Main Authors: | Kristine De La Torre, Elly Cohen, Anne Loeser, Marc Hurlbert, on behalf of the Metastatic Breast Cancer Alliance |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-03-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-017-0010-1 |
Similar Items
-
Moonshot for Precision Medicine
by: Jordi Rodon
Published: (2019-05-01) -
Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
by: Stavros P. Papadakos, et al.
Published: (2022-03-01) -
The National Cancer Institute Cancer Moonshot Public Access and Data Sharing Policy—Initial assessment and implications
by: Tammy M. Frisby, et al.
Published: (2020-01-01) -
Data envelopment analysis to evaluate the efficiency of tobacco treatment programs in the NCI Moonshot Cancer Center Cessation Initiative
by: Kathryn Pluta, et al.
Published: (2023-05-01) -
A COVID moonshot: assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopy
by: Kantsadi, AL, et al.
Published: (2021)